Advanced Semiconductor Engineering, Inc. (ASE), a member of ASE Technology Holding Co., Ltd. (NYSE: ASX, TAIEX: 3711), today ...

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the ...

To address that, Cursor introduced Composer alongside its new multi-agent interface, which allows you to “run many agents in ...

The IDE approval marks a pivotal milestone for Aqua Medical, allowing the company to begin enrolling patients in the U.S. RESTORE-1 pilot trial and study PIMA's potential to deliver durable metabolic ...

Aqua Medical has received investigational device exemption (IDE) from the FDA for its ablation device aimed at treating ...

The fate of Cursor and Replit and the rest could follow a number of paths. Cursor recently announced it is developing its own ...

Contrast Application Security Testing (AST) is a runtime-driven security solution that detects and prioritizes ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

Bristol Myers Squibb to provide idecabtagene vicleucel (ide-cel) for Dispatch’s planned U.S. Phase 1 study, expected to initiate in 2026 Collaboration to accelerate DISP-10 in development for patients ...

Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, today announced the launch of the Simplicity ...

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

Meta today celebrated the culmination of the Meta Llama Impact Accelerator 2025, a program that has brought together some of ...